Showing results (11-20 of 94) with videos related to
Sort By:
Pageof 10
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|May 8, 2010
Endoscopic ultrasound-guided choledochoduodenostomyKazuo Hara, Kenji Yamao, Nobumasa Mizuno, et al.Journal of Gastroenterology|December 3, 2005
Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB): past, present, and futureKenji Yamao, Akira Sawaki, Nobumasa Mizuno, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 15, 2007
[Effect of S-1 in a patient with post-operative recurrence of carcinoma of the ampulla of Vater]Akira Sawaki, Nobumasa Mizuno, Noriyuki Hoki, et al.Journal of Gastroenterology and Hepatology|February 18, 2009
Interventional endoscopic ultrasonographyKenji Yamao, Vikram Bhatia, Nobumasa Mizuno, et al.Cancer Chemotherapy and Pharmacology|January 25, 2008
S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II studyJunji Furuse, Takuji Okusaka, Narikazu Boku, et al.Journal of Gastroenterology|February 14, 2009
Diagnosis of autoimmune pancreatitis using endoscopic ultrasonographyNoriyuki Hoki, Nobumasa Mizuno, Akira Sawaki, et al.Journal of Experimental & Clinical Cancer Research : CR|June 18, 2009
Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancerReiko Ashida, Bunzo Nakata, Minoru Shigekawa, et al.Japanese Journal of Clinical Oncology|March 6, 2019
Efficacy and safety of sunitinib in Japanese patients with progressive, advanced/metastatic, well-differentiated, unresectable pancreatic neuroendocrine tumors: final analyses from a Phase II studyTetsuhide Ito, Masayuki Tori, Satoshi Hashigaki, et al.Surgery Today|March 24, 2006
Laparoscopic wedge resection for gastrointestinal stromal tumors of the stomach: initial experienceYoshinari Mochizuki, Yasuhiro Kodera, Michitaka Fujiwara, et al.International Journal of Clinical Oncology|February 7, 2015
Regorafenib for advanced gastrointestinal stromal tumors following imatinib and sunitinib treatment: a subgroup analysis evaluating Japanese patients in the phase III GRID trialYoshito Komatsu, Toshihiko Doi, Akira Sawaki, et al.Pageof 10